Plasma ACE2 levels predict outcome of COVID-19 in hospitalized patients
View ORCID ProfileTue W. Kragstrup, Helene Søgaard Singh, Ida Grundberg, Ane Langkilde-Lauesen Nielsen, Felice Rivellese, Arnav Mehta, Marcia B. Goldberg, Michael Filbin, Per Qvist, Bo Martin Bibby
doi: https://doi.org/10.1101/2021.03.08.21252819
Tue W. Kragstrup
1Department of Biomedicine, Aarhus University, Denmark
2Department of Rheumatology, Aarhus University Hospital, Denmark
Helene Søgaard Singh
1Department of Biomedicine, Aarhus University, Denmark
Ida Grundberg
3Olink Proteomics, Uppsala, Sweden; Randers Regional Hospital, Randers, Denmark
Ane Langkilde-Lauesen Nielsen
1Department of Biomedicine, Aarhus University, Denmark
Felice Rivellese
5Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Arnav Mehta
6Department of Medical Oncology, Massachusetts General Hospital, Boston, MA, USA
7Broad Institute of MIT and Harvard, Cambridge, MA, USA
Marcia B. Goldberg
8Department of Medicine, Massachusetts General Hospital, Boston, MA, USA
9Department of Microbiology, Harvard Medical School, Boston, MA, USA
Michael Filbin
10Department of Emergency Medicine, Massachusetts General Hospital, Boston, MA, USA
Per Qvist
1Department of Biomedicine, Aarhus University, Denmark
11The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Denmark
12Centre for Genomics and Personalized Medicine, CGPM, Aarhus University, Denmark
Bo Martin Bibby
13Department of Biostatistics, Aarhus University, Denmark
Posted March 10, 2021.
Plasma ACE2 levels predict outcome of COVID-19 in hospitalized patients
Tue W. Kragstrup, Helene Søgaard Singh, Ida Grundberg, Ane Langkilde-Lauesen Nielsen, Felice Rivellese, Arnav Mehta, Marcia B. Goldberg, Michael Filbin, Per Qvist, Bo Martin Bibby
medRxiv 2021.03.08.21252819; doi: https://doi.org/10.1101/2021.03.08.21252819
Plasma ACE2 levels predict outcome of COVID-19 in hospitalized patients
Tue W. Kragstrup, Helene Søgaard Singh, Ida Grundberg, Ane Langkilde-Lauesen Nielsen, Felice Rivellese, Arnav Mehta, Marcia B. Goldberg, Michael Filbin, Per Qvist, Bo Martin Bibby
medRxiv 2021.03.08.21252819; doi: https://doi.org/10.1101/2021.03.08.21252819
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2942)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12743)
- Forensic Medicine (12)
- Gastroenterology (828)
- Genetic and Genomic Medicine (4583)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2916)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (924)
- Medical Education (425)
- Medical Ethics (115)
- Nephrology (469)
- Neurology (4353)
- Nursing (236)
- Nutrition (639)
- Oncology (2268)
- Ophthalmology (646)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1196)
- Primary Care Research (496)
- Public and Global Health (6937)
- Radiology and Imaging (1527)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (488)
- Toxicology (60)
- Transplantation (212)
- Urology (180)